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Abstract Mutations in GJB2 gene are the most frequently found mutations in patients with nonsyndromic
hearing impairment. However, the spectrum and prevalence of mutations in this gene vary among different ethnic
groups. In China, 30,000 infants are born with congenital hearing impairment annually. In order to provide appro-
priate genetic testing and counseling to the families, we investigated the molecular etiology of nonsyndromic deaf-
ness in 103 unrelated school children attending Nantong School for the Deaf and Mute in Jiangsu Province, China.
The coding exon of the GJB2 gene was PCR amplified and sequenced. Sixty two GJB2 mutant alleles were identi-
fied in 35.9% (37/103) of the patients. Twenty five patients carried two pathogenic mutations and 12 patients car-
ried one mutant allele. The 235delC was the most common mutation accounting for 69.4% (43/62) of GJB2 mutant
alleles. The GJB2 mutant alleles accounted for 30.1% (62/206) of all chromosomes responsible for nonsyndromic
hearing impairment. Testing of the 3 most prevalent deleterious frame shift mutations in this cohort detected 100%
of all GJB2 mutant alleles. These results demonstrate that an effective genetic testing of GJB2 gene for patients and
families with nonsyndromic hearing impairment is possible.
Introduction
Hearing impairment is the most common neuro-
sensory disorder in humans that affects approximately
1 in every 1000 children[1]. About half to two thirds of
cases are genetic in etiology. Hereditary deafness is ge-
netically heterogeneous. Non-syndromic deafness ac-
counts for 60-70% of inherited hearing impairment and
involves more than 100 different genes with autosomal
dominant(DFNA), autosomal recessive(DNFB),
X-linked (DFN), and maternal inheritance [2]. The most
common cause of non-syndromic autosomal recessive
hearing loss is mutations in Connexin 26, a gap junc-
tion protein encoded by the GJB2 gene[3-10]. However,
about 30% to 40% of hereditary deafness is syndromic
presenting with other clinical features in addition to
hearing impairment.
Connexins are transmembrane proteins. Six mono-
mers of connexin proteins associate to form a trans-
membrane hexameric gap junction hemi-channel called
connexon. Connexons embedded in the surfaces of ad-
jacent cells associate to form an intercellular channel
[11-12]. In the inner ear, connexin 26 can be in association
with other connexins to form heteromeric connexons,
and gap junction channels can be homotypic or hetero-
typic. The hair cells use connexin 26 gap junction chan-
nels to recycle the potassium ion as part of the mecha-
nism of auditory signal transduction [13-15].
Indeed, mutations in three connexin(Cx) genes,
GJB2 for Cx26, GJB6 for Cx30, and GJB3 for Cx31,
have been identified and known to cause hearing
impairment[16-18]. However, sequence analysis of GJB2
gene in subjects with autosomal recessive hearing
impairment has revealed a puzzling problem - a high
number of patients carry only one mutant allele. Some
of these families show clear evidence of linkage to the
DFNB1 locus, which contains two genes, GJB2 and
GJB6[3,19]. Further analysis demonstrates that a deletion
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truncating the GJB6 gene, which encodes connexin 30,
near GJB2 accompanies in trans in heterozygous
affected subjects [20-21].
To date, more than 100 mutations,
polymorphisms, and unclassified variants have been
described in GJB2 gene accounting for 10-50% of
molecular etiology in patients with nonsyndromic
hearing impairment (http://davinci.crg.es/deafness).
The mutation spectrum and prevalence of mutations
vary significantly among different ethnic groups. Three
mutations, 35delG, 167delT, and 235delC are found to
be the most frequent mutations in Caucasian,
Ashkenazi Jewish, and Asian populations, respectively
[16, 3, 5, 19, 22, 6-10, 23, 24]. A recent multicenter study reported
that the 35delG mutation accounted for 72.44% of
GJB2 mutant alleles in 1,718 patients with biallelic
GJB2 mutations, including delGJB6-D13S1830[25].
Patients in this group were 90% white. In Ashkenazi
Jewish, 35delG and 167delT account for 96% of the
GJB2 mutant alleles[26]. However, the 35delG mutation
is rarely found in Asian patients. Instead, the 235delC
mutation is the most prevalent in Japanese, Korean,
and Taiwanese[22, 6, 10, 27, 28]. Due to the broad mutation
spectrum and variations in mutation frequencies in
various ethnic groups, identification of mutations and
their frequencies in a specific ethnic group is important
in providing accurate genetic counseling and risk
assessment for patients and families.
In China, it is estimated that 30,000 in every 20,
000,000 newborns suffer from congenital hearing
impairment annually[29]. To gain better understanding of
the genetic etiology of deafness in the Chinese
population, we performed a comprehensive genetic
analysis of GJB2 in a cohort of pediatric subjects
attending Nantong School for the Deaf and Mute. We
found that 37 out of 103 (35.9% ) patients with
nonsyndromic hearing impairment carried known
pathogenic mutations
Materials and Methods
Patients and DNA samples
A total of 103 deaf students with an average age
of 12 years (ranging from 6 to 19 years) from 103
unrelated families were identified at Nantong School
for the Deaf and Mute in Jiangsu Province, China. The
study protocol was approved by the Ethics Committee
of the Chinese PLA General Hospital. Informed
consent was obtained from parents of all patients prior
to collecting blood samples. Histories were collected
regarding age at hearing diagnosis, perinatal history,
family history, and other clinical histories including
infection, head or brain injury, and use of
aminoglycoside antibiotics. All patients showed
moderate to profound bilateral sensorineural hearing
impairment on audiograms. DNA specimens from all
patients and 100 Han Chinese controls with normal
hearing were sequenced for detecting mutations and
polymorphisms in the GJB2 gene. DNA was extracted
from peripheral blood leukocytes using commercially
available DNA extraction kit (Watson Biotechnologies
Inc, Shanghai, China).
Mutational analysis
DNA sequence analysis of GJB2 gene was per-
formed through PCR amplification of the coding
exon plus the flanking intron regions followed by
Big Dye sequencing, using forward(5’-TTGGTGTTT-
GCTCAGGAAGA -3' ) and reverse (5'-GGCCTA-
CAGGGGTTTCAAAT-3') primers, located (115bp and
110 bp) upstream and downstream of the GJB2 ORF re-
goin, respectively. The sequence results were analyzed
using an ABI 3100 DNA sequencing machine (ABI
Foster City, USA.) and ABI 3100 Analysis Software
v.3.7 NT, follwoing instructions in the manufacturer’s
manual. The results were compared with the wild type
GJB2 sequence (GenBank accession number: M86849)
to identify mutations.
Results
Sequence analysis of GJB2 gene revealed that 25
patients carried two known pathogenic mutations and
that sixteen patients were heterozygous for one
pathogenic mutant allele（Table 1） in these 103
unrelated deaf families in Nantong, Jiangsu Province,
China.
Three frame-shift mutations （235delC, 299_
300delAT, 176 del16) were identified in this study
(Table 1). The most prevalent mutation in this patient
cohort was GJB2 235delC, which has also been
reported to be the most prevalent in other Asian
populations (Abe et al. 2000; Park et al. 2000). Twelve
patients were homozygous for GJB2 235delC mutation,
10 were compound heterozygous with another
pathogenic mutation, while 9 patients were
heterozygous carriers of GJB2 235delC mutation
(Tables 1). The GJB2 235delC alone accounted for
69.4% (43/62) of the total mutant alleles. Two
mutations, 235delC and 299delAT accounted for
85.5% (53/62) of the GJB2 mutations in our patients.
Three mutations, 235delC, 299delAT and 176 del16
collectively accounted for 100% (62/62) of the GJB2
·· 95
Journal of Otology 2006 Vol. 1 No. 2
Genotype
235delC / 235delC
235delC / 299-300delAT
235delC / 176del 16bp
235delC /257 C > G
235delC / W
176del 16bp / 176del 16bp
176del 16bp / 299-300delAT
176del 16bp / 79G > A
299-300delAT / W
79G>A+341A>G / 79G>A+341A>G
79G>A / 79G>A+341A>G
79G>A +341A>G / W
79G>A+341A>G/109 G > A
79G>A+341A>G / 368C > A
79G>A / 368C >A
79G>A / W
109G>A / W
W / W
Total
Case No.
12
6
4
2
7
1
2
1
2
4
2
21
4
1
2
3
3
26
11
（percentage%）
11.65
5.83
3.88
1.94
6.80
0.97
1.94
0.97
1.94
3.88
1.94
20.39
3.88
0.97
1.94
2.91
2.91
25.24
100.00
Table 1. GJB2 Genotype of patients from Nantong.
Genotype
235delC / W
299-300delAT / W
299-300delAT / 79G>A+341A>G
79G>A+341A>G / 139G>T E47*
79G>A+341A>G / 79G>A+341A>G
79G>A / 79G>A+341A>G
79G>A +341A>G / W
79G>A+341A>G/109 G>A
608T>C/W
79G>A+341A>G/608T>C
109 G>A / W
79G>A / 368C>A
79G>A / 79G>A +368C>A
79G>A+341A>G /438C>T
79G>A / 79G>A
79G>A / W
171G>T / W
W / W
Total
Case No.
1
1
1
1
7
9
25
3
3
3
5
2
1
1
2
6
1
30
100
(percentage %)
1
1
1
1
7
9
25
3
3
3
5
2
1
1
2
6
1
30
100.00
Table 2. GJB2 Genotype of 100 normal con-
trol.
mutations in our patients
In order to clarify the pathogenicity of V37I
(GJB2 109 G > A) variant, we conducted a control
study in a group of 100 individuals with normal
hearing. It was found that the frequency of V37I in the
control individuals(7/100) almost equaled that in the
patients (8/103), The difference was statistically
insignificant. Thus, V37I variant may not be a disease
causing mutation in the Chinese population.
GJB2 gene analysis in the 100 control subjects
showed 4 deleterious mutations (Table 2), giving a
carrier rate of 4% (4/100) in the general population.
Discussion
Previous reports have suggested that the
prevalence of GJB2 mutations varies among different
ethnic groups. In the present investigation, the most
common mutation, 35delG in Caucasians, was not
detected, while the 235delC accounted for 69.4% of
GJB2 mutant alleles in this cohort of Han Chinese.
These results strongly support that the 235delC
mutation in connexin 26 gene is the most prevalent
mutation in Asian populations, including Han Chinese.
Two additional frame-shift mutations, 299delAT and
176 del16, were found in this clinical population. In
fact, these two mutations have been reported in other
Asian populations including Taiwanese, Japanese and
Korean [22··, 6·, 10··, 27··, 28··].
The pathogenicity of V37I is controversial. In a
recent multicenter study, the V37I mutation was
found to be associated with mild to moderate
hearing impairment[25]. This mutation is the
second most common mutation in Japanese,
accounting for 21% of all GJB2 mutant alleles[10]. It has
a frequency of almost 3% in patients but 0.7% in
control[10]. Audiometric evaluation of the patients
harboring homozygous V37I mutation has revealed
that the mutation indeed causes hearing impairment,
although less severe than that caused by 235delC
mutation[30]. This mutation has not been detected in
Korean controls or patients[6]. It is found at lower
frequencies in patients than in controls in Chinese
subjects [27, 28, 31]. In our study, V37I allele was present in
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4% (8/200) of the control population and 3.4% (7/206)
of the patient group, showing no statistically
significant difference of the V37I allele frequency
between the patient and control group（P > 0.05). The
discrepancies may be due to patients'genetic and
environmental backgrounds. All our patients with V37I
were heterozygous without the second mutant allele.
Our data do not support the pathogenicity of V37I
variant, although we cannot rule out the possibility of
predisposition effect by V37I on patients who may
have been exposed to detrimental environmental
factors.
In summary, this study revealed a unique GJB2
mutation spectrum in Chinese patients with
nonsyndromic hearing impairment. The 235delC
mutation appeared to be the most frequent mutation in
deaf patients in Nantong, Jiangsu Province, China.
Testing of three mutations, 235delC, 299_300delAT
and 176 del16, covered all GJB2 mutant alleles in this
clinical population. In order to provide more effective
genetic testing and accurate counseling, it is necessary
to study the genetic etiology of hearing impairment in
other parts of China. Furthermore, the molecular
defects of more than 70% of the patients with
nonsyndromic hearing impairment in China await
being identified.
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